Worldwide Market Reports added Latest Research Report titled “Hemodialysis Access Graft Market – Size, Share, Outlook, and Forecast till 2026” to its Large Report database.
Hemodialysis is a medical procedure involved in removing fluid and waste products from the blood to regulate electrolyte imbalances. Hemodialysis is used to treat acute and chronic kidney failure. A hemodialysis access or vascular access is conducted to reach the blood for hemodialysis by a minor surgery. The access allows blood to travel through soft tubes to the dialysis machine where it is cleaned as it passes through a special filter, called a dialyzer. Hemodialysis patient are accessed by using graft, an access made by using a piece of soft tube to join an artery and vein in arm. Graft is a strong artificial tube inserted by a surgeon underneath the skin of forearm, upper arm or thigh. One end of the tube connects to one of arteries and the other end connects to one of veins, which can be straight or in the shape of a horseshoe.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/195638
Increasing prevalence of Chronic Kidney Diseases (CKD) across the world is major factor driving growth of the hemodialysis access graft market size. Chronic kidney disease (CKD) is the gradual loss of the kidneys’ abilities to perform these essential functions. Factors such as high blood pressure, diabetes, obesity, and smoking are major risk factors for developing CKD. According to the Global Kidney Health Atlas report, 2018, one out of three people in the general population is at increased risk of CKD. Although an estimated 10% of people worldwide have CKD, estimates suggest nine in 10 of those are unaware of their condition. However, high cost of these surgical procedures and lack of skilled healthcare professionals are major factors restraining growth of the hemodialysis access graft market.
Request for Discount @ https://www.worldwidemarketreports.com/discount/195638
Key developments of Hemodialysis Access Graft Market
Market players are engaged in developing novel products to meet increasing demand form healthcare industry and in order to maintain leading position in hemodialysis access graft market. The National Kidney Foundation and Centers for Medicare in the USA established the ‘Fistula Frist Breakthrough Initiative’ in 2003 and revised this to ‘Fistula First, Catheter Last’ in 2007, to encourage and educate dialysis care professionals about the need to avoid catheters and use fistulas whenever possible. Key players operating in hemodialysis access graft market include Vascular Grafts Solutions Ltd., Heart Medical Europe BV, C.R. Bard, Inc., MAQUET Holding B.V. & Co. KG (Getinge Group), Cook Medical, Inc., B. Braun Melsungen AG, Medtronic plc, LeMaitre Vascular, Inc., ARTEGRAFT, and Vascutek Ltd.
Request for Table of Content :https://www.worldwidemarketreports.com/toc/195638
** If you have any special requirements, please let us know and we will offer you the report as you want.
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.
Worldwide Market Reports
1001 4th Ave,
Seattle, WA 98154,
Tel: +1 415 871 0703
Email: [email protected]
Visit our website for more details: https://www.worldwidemarketreports.com
Visit our new website for latest News: https://www.industrychronicle.com